Filtros de búsqueda

Lista de obras de

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

artículo científico publicado en 2016

Atezolizumab in invasive and metastatic urothelial carcinoma.

artículo científico publicado en 2017

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

artículo científico publicado en 2016

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma

artículo científico publicado en 2019

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma

scientific article published on 26 February 2019

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

artículo científico publicado en 2018

Efficacy and Safety of Selective Vascular Endothelial Growth Factor Receptor Inhibitors Compared with Sorafenib for Metastatic Renal Cell Carcinoma: a Meta-analysis of Randomised Controlled Trials.

artículo científico publicado en 2015

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer

artículo científico publicado en 2019

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.

artículo científico publicado en 2017

High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma

scientific article published on 28 March 2019

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy ⬇️

artículo científico publicado el 1 de junio de 2011

Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug development

artículo científico

PD-1 and PD-L1 antibodies in cancer: current status and future directions

artículo científico publicado en 2017

PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials

artículo científico publicado en 2019

PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer

scientific article published on 17 September 2020

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience

article

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

artículo científico publicado en 2019

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

artículo científico publicado en 2019

The impact of taxanes on the management of genitourinary cancers

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda